Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Bordetella pertussis continues to circulate even in populations where a high vaccine
coverage of infants and children is achieved. Cases in adolescents and adults are reported …

Although the introduction of universal pertussis immunisation in infants has greatly reduced
the number of reported cases in infants and young children, disease incidence has been …

Background Pertussis immunization of adults may be necessary to improve the control of a
rising burden of disease and infection. This trial of an acellular pertussis vaccine among …

OBJECTIVES: To describe the clinical course of fatal cases of pertussis and identify
predictors of death at the time of presentation for medical care. METHODS: Case-control …

As part of a prospective acellular pertussis (ACP) vaccine efficacy trial, 5 serum samples
were obtained, over an 18-month period, from 101 ACP-vaccine recipients and 99 control …

Background. The incidence of reported pertussis among adolescents, adults, and young
infants has increased sharply over the past decade. Combined acellular pertussis vaccines …

Pertussis is increasingly recognized as a source of infection in adults who then commonly
infect young children. Immunity to illness caused by Bordetella pertussis is not long-lived, so …

En los últimos años se está observando una reemergencia de la tos ferina en los países con
amplias coberturas vacunales, con la aparición de brotes importantes. Este aumento de la …

Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …